Fresenius reports drug shortage; Lonza, Pharmacyclics extend their pact;

> The U.S. unit of Fresenius Kabi has reported a shortage of chloramphenicol sodium succinate injection to the FDA, citing a shortage of the active pharmaceutical ingredient. Report

> Germany-based Isarna Therapeutics has hired French drugmaker Sanofi ($SNY) to manufacture clinical- and commercial-grade antisense oligonucleotide (ASO) compounds for its development work. Release

> Switzerland-based contract manufacturer Lonza has extended a contract with Pharmacyclics ($PCYC) for the production of the biotech's cancer drug Imbruvica. Release

> Ampio Pharmaceuticals says it has started construction on a manufacturing facility in the Denver, CO, area for its drug candidate for prevalent inflammatory conditions. Release

And Finally... A Pakistani man living in Houston, TX, has pleaded guilty to charges that he imported from China 3,200 counterfeit Viagra and 4,000 counterfeit Cialis pills that he intended to sell. More

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.